March 12, 2020 / 11:21 AM / 18 days ago

BRIEF-Avadel Pharmaceuticals Reports Q4 And Full Year 2019 Financial Results

March 12 (Reuters) - Avadel Pharmaceuticals PLC:

* AVADEL PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.07

* Q4 REVENUE $11 MILLION VERSUS REFINITIV IBES ESTIMATE OF $9.1 MILLION

* SEES Q1 2020 REVENUE $10 MILLION

* REVENUES FOR FOURTH QUARTER OF 2019 WERE $11.0 MILLION, COMPARED TO $20.9 MILLION IN THE FOURTH QUARTER OF 2018

* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE $64.2 MILLION AS OF DECEMBER 31, 2019

* QTRLY LOSS PER SHARE OF $0.07

* REALIZED OVER $80 MILLION IN COST SAVINGS FROM RESTRUCTURING AND OTHER COST REDUCTION ACTIONS

* Q4 EARNINGS PER SHARE VIEW $-0.25 — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below